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OBJECTIVES: Proportion of days covered (PDC) is a common method to measure
medication acquisition behavior. Hospitalizations during an observation period
may impact PDC calculation, because independent medication acquisition behav-
ior during hospital stays is involuntary and cannot be accurately measured. The
purpose of this study was to examine three methods of adjusting for hospital days
when calculating PDC, and assess their impact on PDC. METHODS: Medical and
pharmacy claims from a commercial Midwestern insurer were used. Population
identification criteria included continuously enrolled subjects from January 2007 to
December 2009, with diabetes (medical claim with primary or secondary ICD-9
code 250.xx during 2008 also used to establish index date), no long-term care or
pregnancy, and age greater than 18 years. Observation period was defined as 365
days from index date. PDC (number of days supplied with diabetes drug / number
of days from first diabetes drug acquisition to observation end) was calculated in
three ways: 1) without hospital days adjustment; 2) adjusting the denominator for
hospital days; 3) adjusting the numerator and denominator for hospital days. One
way ANOVA and sensitivity analysis were used to examine the difference in PDC
estimates. RESULTS: A total of 24,072 subjects met study criteria and had mean
hospital days of 0.86 (SD7.09). PDC results were as follows: No hospital days
adjustment 66.16% (SD0.39), adjusting denominator 66.24% (SD0.39), and ad-
justing both numerator and denominator 66.33% (SD0.39). No significant differ-
ence among the three calculation methods was found (p0.889). Sensitivity anal-
ysis indicated that when average total hospital days reached approximately two
days, estimated non-adjusted PDC was significantly lower (p0.05).
CONCLUSIONS: Among subjects with diabetes followed for 365 days, mean total
hospital days was small, and impact on PDC calculations was non-significant. As
total hospital days increase, PDC estimates can be affected and adjusting for hos-
pital days should be considered.
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OBJECTIVES: The objectives of this study were to gain a better understanding of
patient preferences for the attributes of an electronic personal health record (ePHR)
service that supports diabetes self-management, and to gain an understanding of
any factors that might influence their preferences. METHODS: Adaptive choice-
based conjoint analysis was used to examine patient preferences. A web-based
survey was developed comprising six ePHR service attributes. Hierarchical Bayes
estimations were used to quantify patient preferences while Latent Class Analysis
was used to segment the sample. The Patient Activation Measure™ was used to
determine patient level of activation for diabetes self-management. Simulations
and sensitivity analyseswere run to uncover the complex effects of ePHR attributes
on the overall utility of the service. Patients’ willingness to pay was calculated
using simulations of preference shares for three commercially available ePHRs and
increasing the price of the dominant and lowest priced product until it was equally
preferred to its closest rival. RESULTS:A stratified sample of 150 patients with type
1 diabetes, type 2 diabetes, and Prediabetes were unwavering in their preferences
for an Internet-based ePHR service supplied by a physician or specialist. They also
preferred to exchange their health information with their physician or nurse, once
a month, at no cost. Monthly service fees were considered the most important
ePHR service attribute. Patient age and perceived health status are important con-
siderations when designing and marketing an ePHR service. Patients’ level of acti-
vation for diabetes self-management did not appear to play a major role in influ-
encing their preferences. CONCLUSIONS: This study yielded a patient-informed,
evidence-based ePHR service framework that supports diabetes self-management.
Adaptive choice-based conjoint analysis appears to be a useful method for quan-
tifying patient preferences and informing ePHR value propositions and system
design specifications.
Individual’s Health – Clinical Outcomes Studies
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OBJECTIVES: We used a new US population dataset to quantify the burden of
chronic conditions (CCs), using the SF-36v2 Health Survey as a common metric to
test the incremental physical and mental health burden of a comorbid mental CC
among patients with physical CCs; and of a comorbid physical CC among patients
withmental CCs.METHODS:We created four groups: ‘Healthy’ (no lifetimemental
or physical CC); ‘Physical’ (told by MD they had 1 physical but no mental CCs);
‘Mental’ (told they had 1mental but no physical CCs); ‘Physical and Mental’ (1
mental and 1 physical CCs). Each CCwas further classified by diagnostic category.
Multivariate regression models, overall and within gender and diagnosis, yielded
group mean SF-36v2 PCS and MCS scores, controlling for age and group x age
interaction. RESULTS: As expected, the Physical and Mental groups had depressed
PCS andMCS scores (6–7 and 11-12 points, respectively) vs. Healthy subjects. In the
Physical group, a comorbid mental CC further depressed PCS and MCS (3-5 and
13-14 points). In the Mental group, a comorbid physical CC further depressed MCS
and PCS (3 and 10-11 points). Similarly, within the five Physical subgroups, a co-
morbid mental condition further depressed both PCS and MCS (3-5 and 13-15
points). For theMental group, each diagnostic subgroup further depressedMCS and
PCS (4-5 points and 11-16 points). All results persisted across gender.
CONCLUSIONS:Results confirmedour hypotheses. The presence of either a comor-
bid physical or mental CC led to further decrements in both PCS andMCS. Findings
underscore the complexity of managing patients with multiple CCs and impor-
tance of screening for and treating both physical and mental CCs to optimize pa-
tient outcomes. Longitudinal analysis is required to understand the implications of
comorbid CC patterns on health outcomes over time.
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OBJECTIVES: Lead toxicity has been labeled as a major health problem globally
with limited therapeutic options. Literature reveals controversial reports on the
lead detoxifying potential of vitamin C. The aim of this study was to see if vitamin
C supplementation reduces lead levels of blood in adult subjects exposed to lead.
METHODS: After ethical approval and informed consent the traffic police study
subjects (all male) were randomly divided into two groups each containing 40
subjects. One group received 500 mg vitamin C, while the second group was given
1000 mg orally daily for a period of one month. Blood samples were collected at 0,
15, and 30 days of treatment and lead levels were analyzed from the PCSIR Lab,
Karachi using atomic absorption spectrophotometer. RESULTS: The data showed
raised levels of lead in study subjects of both groups (21.74  1.62 and 22.51  1.28
mcg/dl; mean  SEM; N40) compared to the safe limit ( 10 mcg/dl) recom-
mended byWHO. The treatment with vitamin C (500mg) reduced the lead levels to
16.91  1.08 mcg/dl (N 29) after 15 days treatment (P0.01), while the lead level
after 30 days treatment was further reduced to12.61 1.50mcg/dl (N 36; p0.001
compared to control, 21.74  1.62). In the second group subjects, which received
1000mg vitamin C, the lead level after 15 days treatmentwas 15.800.89mcg/dl (N
33; P0.001)), with no further drop (P0.05) after 30 days treatment, as the resul-
tant lead level was 14.64 1.05mcg/dl (N31).CONCLUSIONS:These data indicate
that vitamin C has a dose and time-dependent lead-detoxifying effect and that
vitamin C supplementation may be an effective, safe and economical method in
reducing blood lead levels in chronically exposed subjects such as traffic police.
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Currently 15 US states have laws that regulate insurance coverage for fertility
treatments. Differences between stateswith a comprehensivemandate (2 in vitro
fertilization (IVF) cycles) and non-comprehensive mandate (2 cycles) has been
studied using CDCAssisted Reproductive Technology data, but less is known about
the managed care perspective. OBJECTIVES: To study the impact of state mandate
on in vitro fertilization (IVF) outcomes using a claims database. METHODS: Phar-
Metrics® data for patients with continuous eligibility for 12 months before and
after first gonadotropin-releasing hormone agonist or antagonist prescription (in-
dex date) between January 1, 1999 andMay 31, 2009. Patientswithout a prescription
for follicle stimulating hormone, human chorionic gonadatropin, or evidence of an
embryo transfer within 60 days of index were excluded. Patient descriptors were:
state mandate type (comprehensive versus non-comprehensive), age (38y,38y)
and year of IVF procedure (2005, 2005). ICD-9-CM code for live birth (V27.0,
V27.2, V27.3, V27.5, or V27.6)was evaluated through 42weeks post embryo transfer.
Logistic regression evaluated effects across variables. RESULTS: A total of 880 pa-
tients met study criteria. 49.4% resided in a comprehensive mandate state. Fewer
patients in comprehensive mandate states were identified prior to 2006 (52.0%)
versus non-comprehensive mandate states (58.9%) (P0.0389). The percentage of
patients aged38y was 23.0% in comprehensive versus 17.1% for non-comprehen-
sive mandate states (P0.0284). There was no difference in live births between
comprehensive and non-comprehensivemandate patients (49.2 and 51.5% respec-
tively; P0.5016). Logistic regression results showed that patients38y were more
likely to have a live birth (OR 2.70; 95%CI1.90-3.86); state mandate and year range
showed no association. There were no significant interactions. CONCLUSIONS:
The live birth rate from one IVF cycle in a managed care population was50% and
was not affected by state mandate. Patients with completed IVF before age 38
experienced almost 3 times greater odds of live birth.
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OBJECTIVES: Evaluate comparative effectiveness and economic impacts of banked
donor milk for premature infants to support evidence-based decision-making for
implementing a public milk bank managed by a blood bank in the province of
Québec.METHODS:A systematic review of the literaturewas performed to identify
clinical benefits of banked donor milk compared to formulas for reducing compli-
cations in preterm or very low birthweight (VLBW) infants. Epidemiology and costs
of these complications were obtained from provincial databases (Régie de
l’Assurance Maladie du Québec; Ministère de la Santé et des Services Sociaux) to
estimate the economic impact of using banked donor milk in this vulnerable pop-
ulation. Milk bank budget was estimated in the context of the Québec blood bank.
RESULTS: Evidence available indicates that the major benefit associated with the
use of banked donor milk compared to formula in premature or VLBW infants is a
reduction by 70% of the rate of necrotizing enterocolitis (NEC). Based on historical
data, the incidence rate of NEC in the province of Québec, Canada, was of 70 cases
during a one year-period between 2008 and 2009which resulted in total direct costs
of 2010US$5,426,128 for the Québec healthcare system. It is estimated that the use
of banked donor milk in neonatalogy would reduce the number of NEC cases by 49
and the number of fatalities by 12 annually, resulting in potential savings. It is
proposed that implementing a public milk bank in a blood bank setting would
result in economic efficiencies CONCLUSIONS: Findings of the present study un-
derlines the clinical benefits of banked donor milk compared to formulas in reduc-
ing the incidence of NEC in premature infants. Implementing a public milk bank in
a blood bank setting could be clinically and economically beneficial.
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OBJECTIVES: Atypical femoral diaphyseal fracture and long-term alendronate use
may be linked. The protective effect and the risk of atypical femoral fracture of alen-
dronateandotheranti-osteoporosisdrugs inolderTaiwanesewomenwereevaluated.
METHODS: A population-based retrospective cohort was obtained from the 2000 to
2009 Taiwan National Health Insurance (NHI) data. Subjects hospitalized with verte-
bral or hip fracture to 2007 were selected using 2000 as a run-in year to identify inci-
dent osteoporotic fractures. All patients receiving alendronate, raloxifene, calcitonin
salmon, or teriparatide after index fracture diagnosis formed the treated cohort. An
untreated cohort was obtained accordingly. Patients were followed until endpoint
(hospitalization for hip fracture or atypical femoral diaphyseal fracture) or end of
study period. Cox proportional hazards models were used to assess the association
between alendronate and other anti-osteoporosis drugs and fracture risks. RESULTS:
Among the 11,278 patients (mean age, 77 years), 2,425 (21.5%) received alendronate
(mean follow-up, 1228797days), 2,694 (23.9%) received other anti-osteoporosis drugs
(mean follow-up, 1069639days), and6,159 (54.6%) remaineduntreated (mean follow-
up, 1357835 days). Head-to-head comparisons revealed alendronate’s superiority
(HR 0.77, 95% CI 0.62–0.95) over other anti-osteoporosis drugs in hip fracture preven-
tion. The risk of subsequent hip fracture was significantly reduced (adjusted HR 0.27,
95%CI 0.15–0.78) in long-termalendronateusers. Risk of atypical femoral fracturewas
similar for alendronate versus other anti-osteoporosis drugs (adjustedHR 0.49, 95%CI
0.40–1.47). Short- or long-term alendronate usewas not associatedwith higher risk of
atypical femoral fractures.CONCLUSIONS:Alendronate poses no greater risk of atyp-
ical femoral fracture than other agents, and its benefits in reducing hip fracture risk
significantly outweigh this concern.
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OBJECTIVES: This study evaluated the persistent use of psychotropic polyphar-
macy and characterized how well the cross-sectional operational definitions of
polypharmacy used in published pediatric studies accurately identify patients’
prescribed long-term treatment.METHODS:The prevalence of psychotropic polyp-
harmacy was defined as receiving 14 days, 30 days, 60 days, and 90 days of
overlapping psychotropic prescription fills. Descriptive analysis was used to com-
pare the prevalence findings based on Multistate Medicaid data involving children
and adolescents 6 to 18 years of age. A sensitivity analysiswas conducted to further
explore the extent to which the cross-sectional operational definitions of poly-
pharmacy used in published literature identified patients who were prescribed
psychotropic combinations on a long-term basis. RESULTS: Analysis of Multistate
Medicaid data revealed that 218,696 children and adolescents filled at least one
psychotropic prescription in 2005. Of these patients, 22.52% received psychotropic
combinations for 14 consecutive days. The observed rate of polypharmacy
dropped to 21.07% with 30 days overlap criterion and to 16.44% with 60 days
overlap criterion. 25%-60% of patients with polypharmacy in cross-sectional defi-
nitions were likely receiving two or more psychotropic agents on a short-term
basis.. Furthermore, cross-sectional definitions failed to identify a 40% to 70% of
patients on long-term polypharmacy (60 day overlap). CONCLUSIONS: The long-
term use of psychotropic polypharmacy in Medicaid children and adolescents in
this study appeared modest. The comparison between our observations and pre-
vious studies illustrate the considerable problems that arise when comparing rates
of polypharmacy across studies with inconsistent operational definitions.
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OBJECTIVES: To determine the prevalence of potentially inappropriatemedication
(PIM) use among older adults in theUSA in 2007 and compare the prevalence to that
in 1996, and to identify risk factors for PIMuse.METHODS: Primary data sourcewas
the 2007 Medical Expenditure Panel Survey. This is a nationally representative
survey of the U.S. community-dwelling population. Study subjects were those re-
spondents aged 65 or older. A retrospective cohort studywas conducted. PIMswere
identified according to the Zhan criteria. Prevalence rates of the 33 PIMs utilization
bymedications and respondents’ characteristics were determined. Risk factors for
PIM use were examined using logistic regression after controlling for confounding
factors.RESULTS:The 33 PIMsuse on the Zhan list declined between 1996 and 2007.
In 2007, 13.8% (95% confidence interval [CI], 12.5%–15.2%) of the elderly or 5.4 mil-
lion older adults received at least 1 of the 33 PIMs; and 1.5% (95%CI, 1.1%–2.0%) used
at least 1 of the 11 PIMs that should always be avoided. The most commonly
misused medications were propoxyphene, amitriptyline, antihistamines, diaze-
pam, muscle relaxants, gastrointestinal antispasmodics, and indomethacin. High-
risk older patients for PIM use included women, people in the South, persons re-
ceiving more prescriptions, and those who rated their health status as fair and
poor. Comparing to data in 1996, the prevalence of PIMs decreased from 6.9million
to 5.4 million although the top three PIMs remained propoxyphene, amitriptyline
and promethazine. The older people who took at least 1 of the 11 PIMs declined
from 0.84 million to 0.59 million. CONCLUSIONS: The 33 PIMs use in older Ameri-
cans decreased butwas still prevalent in some subgroups and for some drugs. Drug
utilization review for elderly population is still needed.
Individual’s Health – Cost Studies
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OBJECTIVES: The purpose of this study is to describe health service use and related
costs associated with potentially inappropriate prescriptions (PIP) of benzodiaz-
epines (BZD) in the elderly living in the community in the province of Quebec,
Canada. METHODS: The cohort consisted of a representative sample (n2494) of
Quebec’s community-dwelling elderly (65 years of age) respondents of the ESA
survey (Survey on older adult’s mental health, 2006). The cost analysis was carried
out from a healthcare system perspective and the definition of the PIP of benzodi-
azepines was based on Beers’ criteria (Fick, 2003). Multivariate regression analyses
were carried out to assess the influence of PIP of BZD on healthcare costs in the
elderly. RESULTS: 30% (n744) of participants were using BZD and 45% (n331) of
the users received at least one PIP. Higher healthcare costs (14196$ vs. 9992$; p
0.0001) were observed for participants with the presence of PIP of BZD in compar-
ison with those without PIP. When individual and health care system factors were
controlled, health care costs were still higher for BZD users with PIP without being
statistically significant at a 95% level ( (log($))  0.109; IC95: [-0.040, 0.259]; 	 $ :
1180$). Factors associated with higher healthcare costs were gender and physical
health status. CONCLUSIONS: Using both administrative and survey data, this
study provides new data that will help decision makers better understand the
economic impact associated with the inappropriate prescriptions of BZD. The sig-
nificant association between the PIP of BZD and the healthcare costs observed in
the univariate analysis seems to be mainly explained by the patient’s physical
health status. Nonetheless, with the current economic and clinical context, partic-
ular attention should be given to the inappropriate prescriptions of BZD, affecting
45% of users and 14% of the senior population in Québec.
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COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE
MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR
SUSTAINABILITY IN GHANA
Odame E
Ghana Health Service, ACCRA, Ghana
OBJECTIVES: Themain objective of this study was therefore to examine the cost of
the freematernal health services to the southern part of Ghana and explore factors
that contribute to these costs. METHODS: Available routine financial claim records
for 2009 were used to compile the cost information for the various maternal services
usingacompilation sheet for the threenational insurance schemeaccredited facilities
and the scheme office in the area. The financial cost of antenatal, postnatal, delivery,
abortion and the overall costs of all the maternal health services were obtained by
facility type for both services and drugs. RESULTS: Among other findings, we found
that average cost for Ridge hospital antenatal GH¢14.28(US$9.85), postnatal
GH¢63.54(US$43.82) andnormal deliveriesGH¢51.03(US$35.19)whereas that forAdab-
raka Polyclinic antenatal GH¢15.12(US$10.43), postnatal GH¢24.03(US$16.58) and nor-
mal deliveries GH¢37.64(US$25.96). The results of the study showed that
GH¢1,358,647.98(US$936,998.61) was spent in 2009 for maternity services for Osu-
Klottey sub-metro and this represented about 7.7%of expenditure of theBritishGrant.
The financial cost of antenatal care was GH¢289,094.96(US$199,375.83), postnatal
care was GH¢159,913.34(US$110,285.06) and spontaneous vaginal delivery was
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